ROCHE RESISTS PRESSURE TO CUT FLU DRUG PRICE

The manufacturer of the main drug to treat pandemic flu stood firm on Wednesday against pressure to cut prices in the developing world, while saying it would be able to fulfil all current orders by 2007. William Burns, head of pharmaceuticals at Roche of Switzerland, said his company already offered the medicine, Tamiflu, to governments for pandemic stockpiles at a substantial discount to its normal price, and ruled out further reductions.

Financial Times (http://news.ft.com/cms/s/be6e894a-5177-11da-ac3b-0000779e2340.html)